Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
about
Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins.Salmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.Characterization of fluorescent chimeras of cholera toxin and Escherichia coli heat-labile enterotoxins produced by use of the twin arginine translocation systemHeteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems.Structure-guided design and immunological characterization of immunogens presenting the HIV-1 gp120 V3 loop on a CTB scaffold.Helicobacter pylori vaccines: lessons from small animal models.A Vibrio cholerae ghost-based subunit vaccine induces cross-protective chlamydial immunity that is enhanced by CTA2B, the nontoxic derivative of cholera toxin.Immunization for protection of the reproductive tract: a review.Dental caries vaccines: prospects and concerns.Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxinsCholera toxin B: one subunit with many pharmaceutical applications.Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.Bacterial Toxin Fusion Proteins Elicit Mucosal Immunity against a Foot-and-Mouth Disease Virus Antigen When Administered Intranasally to Guinea PigsImmunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections.Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in miceThe Quest for an HIV-1 Vaccine Adjuvant: Bacterial Toxins as New Potential Platforms.Identification and characterization of gonococcal iron transport systems as potential vaccine antigens.Identification and characterization of intestinal antigen-presenting cells involved in uptake and processing of a nontoxic recombinant chimeric mucosal immunogen based on cholera toxin using imaging flow cytometry.The Type II heat-labile enterotoxins LT-IIa and LT-IIb and their respective B pentamers differentially induce and regulate cytokine production in human monocytic cells.Characterization of a Salmonella Typhimurium ghost carrying an adjuvant protein as a vaccine candidate for the protection of chickens against virulent challenge.
P2860
Q33715999-7033B403-B935-4B5D-9908-00EF0987CF9AQ33716162-ED6C8A56-B591-497A-A424-249C04290FDBQ33743411-DE81A200-72F9-480C-AD27-4315F5D7928BQ33768109-6B2CCA4F-C194-457F-BF80-7849D2E36934Q33768922-5209D7AE-647F-4C65-96AE-2CB91F420CA7Q33788186-50240B89-7374-4F75-8D15-2C69BA8A37FBQ34034242-CC004C7A-B2AF-4782-9023-9F07117A5FC8Q34128200-47BA2184-5F3A-4C87-B5C2-E8E1FB636E39Q34222745-98521A23-0392-4C04-8EB5-E8EA03001921Q34708547-5C5F1857-4588-4B12-A457-BF2E148EF953Q34767024-55DB9E1E-8EA3-4521-9640-52D8F7C93572Q34793368-972CF725-33C7-4103-92E4-A0E844EEB5F1Q34972133-8FB4C209-B43E-4BF1-80DA-D9DF92E00D5CQ35232735-F47E305B-F5E3-4E39-B0FE-0D1027BD342DQ35689341-FD369D09-90D9-4FB5-B86A-29163B066DEBQ35692346-331B186D-4F90-4790-94F0-9551AB35C49DQ36320323-CF0B3988-ACDA-4523-B036-B25106B63982Q36427185-1066AE73-CCF4-4A08-8B7A-3B19495E030CQ37057983-14571911-6A71-45AC-86FE-8A169C02466AQ37133395-FF60C06B-DBA5-46FC-8453-89E1CEE8AA95Q37544969-6FBD571D-96F7-4A37-85FE-6FFD4872D596Q40205845-B1079FCA-5F42-44CF-BF55-F5363568AE05Q41729708-6040176C-CAA2-4128-9D9D-42716305E3BE
P2860
Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Recombinant antigen-enterotoxi ...... dependent costimulation of CD4
@nl
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@ast
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@en
type
label
Recombinant antigen-enterotoxi ...... dependent costimulation of CD4
@nl
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@ast
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@en
prefLabel
Recombinant antigen-enterotoxi ...... dependent costimulation of CD4
@nl
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@ast
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@en
P2093
P2860
P1476
Recombinant antigen-enterotoxi ...... stimulation of CD4(+) T cells.
@en
P2093
D J Metzger
G Hajishengallis
M W Russell
S M Michalek
T D Connell
P2860
P304
P356
10.1128/IAI.69.1.252-261.2001
P407
P577
2001-01-01T00:00:00Z